InBody Co.,Ltd (KOSDAQ:041830)

Market Cap	388.32B
Revenue (ttm)	226.62B
Net Income (ttm)	32.83B
Shares Out	12.19M
EPS (ttm)	2,626.56
PE Ratio	12.13
Forward PE	11.20
Dividend	400.00 (1.35%)
Ex-Dividend Date	Mar 28, 2025

Volume	48,651
Average Volume	40,418
Open	32,000
Previous Close	31,850
Day's Range	31,050 - 32,450
52-Week Range	20,700 - 32,650
Beta	0.40
RSI	61.83
Earnings Date	Nov 11, 2025

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. It offers body composition analyzers, automatic blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 1996
• Employees: 342
• Stock Exchange: KOSDAQ
• Ticker Symbol: 041830

Financial Performance

In 2024, InBody Co.,Ltd's revenue was 204.46 billion, an increase of 20.03% compared to the previous year's 170.35 billion. Earnings were 33.14 billion, a decrease of -9.75%.